News
Pfizer saw a staggering increase in call options trading, with investors snapping up 539,824 contracts, marking a 286% jump ...
Pharma’s next big leap won’t come from the lab. It’ll come from outside the lab, where the rules of narrative, attention, and ...
Bristol Myers (BMY) delivered an impressive performance in the past month after being under pressure for quite some time. The ...
The Swiss drugmaker discussed the option of selling drugs directly to patients with U.S. officials following Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results